Oehler E, Soubiran G, Fabiani B, Legrand O, Rio B, Ghawche F. [Macrophage activation syndrome as the presenting manifestation of intravascular lymphoma].
Rev Med Interne 2013;
34:636-40. [PMID:
23660185 DOI:
10.1016/j.revmed.2012.10.001]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2012] [Revised: 08/29/2012] [Accepted: 10/01/2012] [Indexed: 11/15/2022]
Abstract
INTRODUCTION
Intravascular large B cell lymphoma is a neoplastic cell proliferation leading to the occlusion of the lumen of small vessels. This is a rare haematological malignancy, which is difficult to diagnose because of a heterogeneous clinical presentation.
CASE REPORT
We report a 62-year-old man who presented a macrophage activation syndrome as the presenting manifestation of an intravascular lymphoma. This association is frequently marked by a greater severity and clinical care requires an early and appropriate treatment.
CONCLUSION
Due to the polymorphism and the systemic presentation of intravascular large B cell lymphoma, the internist may be confronted with this disease, which is considered to be more severe if associated with a macrophage activation syndrome. Awareness of the intravascular large B cell lymphoma is important because the prognosis depends on the rapidity of the initiation of chemotherapy associated with rituximab.
Collapse